Quinuclidine derivatives and their pharmaceutical use
US7750022B2 · kind B2 · utility
3Cited by
9References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2004 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Feb 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to novel quinuclidine derivatives and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.